Comparison of monotherapy and combination therapy for older patients with advanced biliary tract cancer: a retrospective study

被引：0
|
作者：
Ritsuko Oishi [1 ]
Satoshi Kobayashi [2 ]
Shuhei Nagashima [1 ]
Taito Fukushima [1 ]
Shun Tezuka [1 ]
Manabu Morimoto [1 ]
Makoto Ueno [1 ]
Shin Maeda [2 ]
机构：
[1] Kanagawa Cancer Center,Department of Gastroenterology
[2] Yokohama City University Medical Center,Gastroenterological Center
[3] Yokohama City University Graduate School of Medicine,Department of Gastroenterology
来源：
BMC Cancer | / 25卷 / 1期
关键词：
Geriatrics; Gemcitabine; Cisplatin; S-1; Biliary tract cancer; Monotherapy; Combination therapy; Systemic chemotherapy; And prognosis;
D O I：
10.1186/s12885-025-14014-1
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Gemcitabine and S-1 Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer: A Retrospective Study
    Mita, Kazuhito
    Ito, Hideto
    Fukumoto, Masato
    Murabayashi, Ryo
    Nabetani, Masashi
    Koizumi, Kazuya
    Hayashi, Takashi
    CASE REPORTS IN ONCOLOGY, 2010, 3 (03): : 498 - 504
  • [2] Survival by line of therapy of older patients with advanced biliary tract cancer (BTC)
    Bobiak, Sarah
    Danese, Mark D.
    Lubeck, Deborah P.
    Gleeson, Michelle L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [3] A Retrospective Study of Gemcitabine and Cisplatin Combination Therapy as Second-Line Treatment for Advanced Biliary Tract Cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Akiyama, Dai
    Yagioka, Hiroshi
    Kogure, Hirofumi
    Matsubara, Saburo
    Ito, Yukiko
    Yamamoto, Natsuyo
    Sasahira, Naoki
    Hirano, Kenji
    Toda, Nobuo
    Tada, Minoru
    Koike, Kazuhiko
    CHEMOTHERAPY, 2013, 59 (02) : 106 - 111
  • [4] A retrospective study of gemcitabine and cisplatin combination therapy as second-line treatment for advanced biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Akiyama, Dai
    Yagioka, Hiroshi
    Kogure, Hirofumi
    Matsubara, Saburo
    Ito, Yukiko
    Yamamoto, Natsuyo
    Sasahira, Naoki
    Hirano, Kenji
    Toda, Nobuo
    Tada, Minoru
    Koike, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] A Retrospective Study of S-1 Monotherapy as Second-line Treatment for Patients with Advanced Biliary Tract Cancer
    Kobayashi, Satoshi
    Ueno, Makoto
    Ohkawa, Shinichi
    Andou, Tomoko
    Kameda, Ryo
    Yamamoto, Naoto
    Morinaga, Soichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (09) : 800 - 806
  • [6] Efficacy and Safety of Gemcitabine Monotherapy for Patients with Advanced Biliary Tract Cancer
    Yokoyama, Tadashi
    Yoshida, Hiroshi
    Makino, Hiroshi
    Maruyama, Hiroshi
    Suzuki, Seiji
    Matsutani, Takeshi
    Matsushita, Akira
    Hirakata, Atsushi
    Sasajima, Koji
    Uchida, Eiji
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2012, 79 (03) : 204 - 212
  • [7] S-1 Monotherapy in Patients with Advanced Biliary Tract Cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Yashima, Yoko
    Yagioka, Hiroshi
    Kogure, Hirofumi
    Arizumi, Toshihiko
    Togawa, Osamu
    Matsubara, Saburo
    Ito, Yukiko
    Nakai, Yousuke
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Tada, Minoru
    Kawabe, Takao
    Omata, Masao
    ONCOLOGY, 2009, 77 (01) : 71 - 74
  • [8] A Pilot Study of Salvage Irinotecan Monotherapy for Advanced Biliary Tract Cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Takahara, Naminatsu
    Satoh, Yumiko
    Takai, Daiya
    Kogure, Hirofumi
    Yamamoto, Natsuyo
    Hirano, Kenji
    Tada, Minoru
    Yatomi, Yutaka
    Koike, Kazuhiko
    ANTICANCER RESEARCH, 2013, 33 (06) : 2619 - 2622
  • [9] A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Ito, Yukiko
    Yasuda, Ichiro
    Toda, Nobuo
    Kogure, Hirofumi
    Hanada, Keiji
    Maguchi, Hiroyuki
    Sasahira, Naoki
    Kamada, Hideki
    Mukai, Tsuyoshi
    Okabe, Yoshihiro
    Hasebe, Osamu
    Maetani, Iruru
    Koike, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 973 - 979
  • [10] A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Ichiro Yasuda
    Nobuo Toda
    Hirofumi Kogure
    Keiji Hanada
    Hiroyuki Maguchi
    Naoki Sasahira
    Hideki Kamada
    Tsuyoshi Mukai
    Yoshihiro Okabe
    Osamu Hasebe
    Iruru Maetani
    Kazuhiko Koike
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 973 - 979
12345